Biopharma Insights

Generative Diffusion in Molecular Design

A quick field guide to diffusion-based generators in molecular design—how they work, where they complement transformers, and who is deploying them today. Last week, Californian drug discovery startup Terray Therapeutics …

Continue ›››

9 Companies Using Artificial Intelligence to Fight Infectious Diseases

Development of a novel drug is a tedious process that requires immense investments of resources and time—on average, it takes from 8-10 years and capitalized R&D costs are reported between …

Continue ›››

Three Big Ideas in Aging Research That Could Shift the Therapeutic Landscape

Drawing on new discussions from ARDD2025 in Copenhagen, the focus turns to how GLP-1s, IPF, and the gut microbiome are steering aging drug development Over the past decade, aging research …

Continue ›››

13 Publicly Traded Companies Developing Longevity Therapeutics

Aging research shifted from watching what happens to testing what can be changed. In the 1930s, lab studies in rats showed that eating fewer calories without malnutrition extended life —a …

Continue ›››

Protein Language Models: Builders & Pharma Deals

Chan Zuckerberg Initiative, the group behind the recent virtual cell efforts, has “acqui-hired” EvolutionaryScale’s ~50-person team, folding it into the expanding Biohub network. The move comes as CZI pivots to …

Continue ›››

22 Life Science Marketplaces to Try in 2025

A life sciences marketplace is an online platform that operates with a "many-to-many" business logic, hosting multiple suppliers and buyers interacting via various e-commerce tools available as part of the website's functionality.

Continue ›››

New LLMs, Agents, and Graphs in Life Sciences

In recent weeks, Anthropic announced “Claude for Life Sciences” as an AI framework for assisting life science researchers. The release is one of several recent moves by general-purpose AI vendors …

Continue ›››

Five Companies Leading the Way in 3D Bioprinting

Lately, bioprinting is shifting from proof-of-concept prints to regulated workflows and early clinical use. In July 2022 in San Antonio, Texas, surgeons performed the first human ear reconstruction using a …

Continue ›››

Roche and Manifold Bio's up-to-$2B Deal to Develop Next-Gen Brain Shuttles for Neurological Diseases

Manifold Bio, a Boston-based platform therapeutics company, announced a strategic collaboration and license agreement with Roche to develop several next-generation blood-brain barrier (BBB) shuttles intended for neurological and neurodegenerative disease …

Continue ›››